Sumitomo Pharma Co., Ltd.: all 273 studies

Page 3 of 3. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• Study of DSP-7888 in Patients With Myelodysplastic SyndromeCompletedNCT02436252Phase 1/2
• A Study of BBI608 and BBI503 Administered in Combination to Adult Patients With Advanced Solid TumorsCompletedNCT02432326Phase 1
• Dasotraline Pediatric ADHD StudyCompletedNCT02428088Phase 2/3
• A Study of BBI608 Administrated With Sorafenib in Adult Patients With Advanced Hepatocellular CarcinomaCompletedNCT02358395Phase 1
• A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT02354898Phase 1
• A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic MalignanciesCompletedNCT02352558Phase 1
• Dasotraline Adult ADHD StudyCompletedNCT02276209Phase 3
• A Study of BBI503 in Adult Patients With Advanced Urologic MalignanciesWithdrawnNCT02232646Phase 2
• A Study of BBI503 in Adult Patients With Advanced Hepatobiliary CancerCompletedNCT02232633Phase 2
• A Study of BBI503 in Adult Patients With Advanced Gastrointestinal Stromal TumorsTerminatedNCT02232620Phase 2
• A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic CancerCompletedNCT02231723Phase 1
• Dasotraline SEP360-105 Pediatric PK/PD StudyCompletedNCT02195167Phase 1
• Open-label Safety Study in Adults With ADHDCompletedNCT02160262Phase 3
• Phase 1 Study With OAB Assessing the Safety and Activity of hMaxi-K Gene TransferCompletedNCT01870037Phase 1
• A Study of BBI503 in Adult Patients With Advanced Solid TumorsCompletedNCT01781455Phase 1
• A Study of BBI608 in Adult Patients With Advanced MalignanciesCompletedNCT01775423Phase 1
• A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and Its Metabolites in Healthy Subjects and in Subjects With Major Depressive DisorderTerminatedNCT01774747Phase 1
• Twelve Month Study of the Safety of Eszopiclone in Adult Subjects With InsomniaCompletedNCT01710631Phase 3
• A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With AsthmaCompletedNCT01656811Phase 2
• Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety DisorderCompletedNCT01614041Phase 4
• A Phase 1, Open-Label, Single-photon Emission Computed Tomography (SPECT) Study to Evaluate Serotonin and Dopamine Transporter Occupancy After Multiple Dose Administration of SEP-228432 to Achieve Steady State in Healthy SubjectsCompletedNCT01531972Phase 1
• Major Depressive Disorder With Mixed FeaturesWithdrawnNCT01423240Phase 3
• Effect of Arotinolol Hydrochloride on Cardiovascular Events in Hypertensive Haemodialysis PatientsCompletedNCT01351636Phase 4
• Amrubicin (AMR) Trial in Patients With Non-small Cell Lung CancerCompletedNCT01207011Phase 3
• DSP-3025 A Phase 1 Study of Healthy Male VolunteersCompletedNCT01124396
• Digoxin Drug-Drug Interaction With Lurasidone HClCompletedNCT01082289Phase 1
• Rifampin Drug-Drug Interaction Study With Lurasidone HClCompletedNCT01082276Phase 1
• Midazolam Drug-Drug Interaction Study With Lurasidone HClCompletedNCT01082263Phase 1
• The Bioequivalence Of Two Different Lurasidone Formulations In PatientsCompletedNCT01082250Phase 1
• RI-AME Study OF [ISOTHIAZOLYL-3-14C]-LURASIDONECompletedNCT01082146Phase 1
• Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HClCompletedNCT01074632Phase 1
• Lithium Drug-Drug Interaction Study With Lurasidone HClCompletedNCT01074073Phase 1
• Safety, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Patients With Type 2 Diabetes Mellitus and Healthy AdultsCompletedNCT01042106Phase 1
• DSP-3025 Study of Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of SeasonCompletedNCT00925678Phase 1
• Serum-Free Thymus Transplantation in DiGeorge AnomalyTerminatedNCT00849888Phase 1
• A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00691405Phase 2
• A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00685841Phase 3
• Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00685529Phase 2
• Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic AlbuterolCompletedNCT00685425Phase 3
• Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric SubjectsCompletedNCT00685347Phase 2
• Safety and Efficacy of Eszopiclone With Mild to Moderate Obstructive Sleep Apnea Syndrome (OSAS)CompletedNCT00685269Phase 2
• Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD)CompletedNCT00685126Phase 3
• Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With AsthmaCompletedNCT00685022Phase 2
• Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With AsthmaCompletedNCT00684866Phase 2
• A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With AsthmaCompletedNCT00684827Phase 2
• Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) SubjectsCompletedNCT00667797Phase 4
• Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in AsthmaCompletedNCT00667407Phase 3
• Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00665600Phase 3
• Phase I Study of Umbilical Cord Blood Transplantation Followed by Third Party Thymus TransplantationTerminatedNCT00597441Phase 1
• A Safety, Efficacy and Tolerability Study of SEP-225289CompletedNCT00584974Phase 2
• Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPDCompletedNCT00583986Phase 3
• Thymus Transplantation With ImmunosuppressionCompletedNCT00579709Phase 1
• Parathyroid and Thymus Transplantation in DiGeorge #931CompletedNCT00566488Phase 1
• A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female SubjectsCompletedNCT00549666Phase 1
• Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor OveractivityTerminatedNCT00495053Phase 1
• A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and InsomniaCompletedNCT00435279Phase 3
• Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy VolunteersCompletedNCT00368160Phase 1
• Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving AbilityCompletedNCT00368056Phase 3
• A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive DisorderCompletedNCT00368030Phase 3
• Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid ArthritisCompletedNCT00367965Phase 3
• Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/MenopauseCompletedNCT00366093Phase 3
• 6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary InsomniaCompletedNCT00352144Phase 3
• Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114TerminatedNCT00296257Phase 2
• Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC)TerminatedNCT00286169Phase 3
• Efficacy Study of Single-Dose Levalbuterol Tartrate HFA MDI Vs Placebo in Subjects 18 Years and Older With EIBCompletedNCT00268723Phase 3
• Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety DisorderCompletedNCT00235508Phase 4
• Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor PolyneuropathyCompletedNCT00101426Phase 3
• Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With AsthmaCompletedNCT00073840Phase 3
• Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With AsthmaCompletedNCT00073827Phase 3
• Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With AsthmaCompletedNCT00073814Phase 3
• To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPDCompletedNCT00064415Phase 3
• Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPDCompletedNCT00064402Phase 3
• Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With AsthmaCompletedNCT00064389Phase 3

← Sumitomo Pharma Co., Ltd. overview and focus areas